The China Mail - US authorizes first condom for use in anal sex

USD -
AED 3.673096
AFN 62.501853
ALL 81.576868
AMD 368.780043
ANG 1.79046
AOA 917.999857
ARS 1391.583196
AUD 1.384572
AWG 1.8025
AZN 1.698524
BAM 1.670681
BBD 2.014496
BDT 122.776371
BGN 1.66992
BHD 0.377303
BIF 2975
BMD 1
BND 1.273528
BOB 6.911397
BRL 5.002099
BSD 1.000201
BTN 95.835344
BWP 14.087599
BYN 2.794335
BYR 19600
BZD 2.011549
CAD 1.37274
CDF 2244.999557
CHF 0.783415
CLF 0.022712
CLP 893.879859
CNY 6.78515
CNH 6.78631
COP 3791.42
CRC 454.512452
CUC 1
CUP 26.5
CVE 94.714208
CZK 20.82465
DJF 177.720507
DKK 6.40006
DOP 59.701874
DZD 132.610989
EGP 52.874495
ERN 15
ETB 156.163199
EUR 0.85643
FJD 2.189701
FKP 0.739691
GBP 0.746185
GEL 2.679725
GGP 0.739691
GHS 11.410232
GIP 0.739691
GMD 72.502255
GNF 8779.999938
GTQ 7.630738
GYD 209.246802
HKD 7.832595
HNL 26.599525
HRK 6.454603
HTG 130.972363
HUF 306.388025
IDR 17545.5
ILS 2.902602
IMP 0.739691
INR 95.69355
IQD 1310.201083
IRR 1315000.000029
ISK 122.979764
JEP 0.739691
JMD 158.141561
JOD 0.708988
JPY 158.191499
KES 129.250067
KGS 87.450391
KHR 4012.000269
KMF 422.00025
KPW 899.97066
KRW 1492.530257
KWD 0.30842
KYD 0.833543
KZT 473.448852
LAK 21954.999541
LBP 89550.000072
LKR 325.320759
LRD 183.250012
LSL 16.418345
LTL 2.95274
LVL 0.60489
LYD 6.348556
MAD 9.176212
MDL 17.192645
MGA 4189.000457
MKD 52.78458
MMK 2099.865061
MNT 3580.130218
MOP 8.069362
MRU 39.968052
MUR 46.899865
MVR 15.410136
MWK 1733.971717
MXN 17.220704
MYR 3.931498
MZN 63.901853
NAD 16.418345
NGN 1371.039687
NIO 36.808139
NOK 9.229603
NPR 153.332792
NZD 1.690095
OMR 0.384499
PAB 1.000184
PEN 3.418655
PGK 4.357259
PHP 61.590076
PKR 278.576188
PLN 3.633385
PYG 6094.852476
QAR 3.645884
RON 4.453802
RSD 100.543734
RUB 73.248122
RWF 1462.916693
SAR 3.759074
SBD 8.032258
SCR 14.650317
SDG 600.501765
SEK 9.34834
SGD 1.275345
SHP 0.746601
SLE 24.607781
SLL 20969.502105
SOS 571.616491
SRD 37.207019
STD 20697.981008
STN 20.928276
SVC 8.751249
SYP 110.528733
SZL 16.40606
THB 32.372497
TJS 9.346574
TMT 3.51
TND 2.914168
TOP 2.40776
TRY 45.435598
TTD 6.790867
TWD 31.526502
TZS 2594.999679
UAH 43.968225
UGX 3740.52909
UYU 39.831211
UZS 11992.073051
VES 508.06467
VND 26345
VUV 118.077659
WST 2.708521
XAF 560.318959
XAG 0.01183
XAU 0.000214
XCD 2.70255
XCG 1.802565
XDR 0.694969
XOF 560.316565
XPF 101.873721
YER 238.625029
ZAR 16.48058
ZMK 9001.203062
ZMW 18.82781
ZWL 321.999592
  • BCE

    -0.1150

    24.275

    -0.47%

  • JRI

    0.0150

    13.145

    +0.11%

  • CMSC

    -0.0101

    23.0401

    -0.04%

  • RBGPF

    -0.2100

    60.79

    -0.35%

  • CMSD

    0.0050

    23.565

    +0.02%

  • GSK

    -0.0550

    50.935

    -0.11%

  • BCC

    3.1100

    70.09

    +4.44%

  • RIO

    -2.2900

    109.75

    -2.09%

  • NGG

    -0.0550

    86.925

    -0.06%

  • AZN

    -2.1650

    185.555

    -1.17%

  • RELX

    -0.0900

    31.53

    -0.29%

  • BP

    0.1550

    44.295

    +0.35%

  • RYCEF

    0.1200

    16.12

    +0.74%

  • VOD

    0.0250

    15.535

    +0.16%

  • BTI

    1.4250

    66.775

    +2.13%

US authorizes first condom for use in anal sex
US authorizes first condom for use in anal sex

US authorizes first condom for use in anal sex

The US Food and Drug Administration (FDA) on Wednesday authorized the first condom for use during anal intercourse, in what was hailed as a victory for sexual health by experts.

Text size:

Although people already use condoms for anal sex -- as is recommended by health agencies including the Centers for Disease Control and Prevention (CDC) -- regulators across the world had only previously allowed companies to officially market their products as "safe and effective" for vaginal use.

Sexual health advocates considered this an unmet public health need since unprotected anal intercourse carries the greatest risk of HIV transmission via sexual exposure, with one study finding that 69 percent of men who have sex with men would use condoms more frequently if they were FDA-indicated.

Wednesday's authorization of Global Protection Corp's One Male Condom follows a clinical trial involving more than 500 people, carried out by Emory University.

"The FDA's authorization of a condom that is specifically indicated, evaluated and labeled for anal intercourse may improve the likelihood of condom use during anal intercourse," said agency scientist Courtney Lias in a statement.

The condom is also indicated to prevent sexually transmitted infections -- and as a contraceptive -- during vaginal sex.

"We want people to have lots of sex -- but we also want them to be empowered and informed," said Davin Wedel, president of Global Protection Corp, which makes the condom brand that is available in 54 sizes, and incorporates a paper template to help each user find the right size.

The clinical trial involved 252 men who have sex with men and 252 men who have sex with women, aged between 18 and 54.

The FDA had said it would accept a five percent failure rate, which previous trials had failed to accomplish. The limit was easily surpassed in the new study, with the failure rate 0.68 percent for anal and 1.89 percent for vaginal intercourse.

The researchers behind the study, which was published in The Lancet's eClinicalMedicine, said one of the reasons the trial succeeded where others failed in the past was likely due to the provision of lubricant and inclusion of instructions on how to use the product.

Lubricant reduces friction, which in turn causes condom failure from slippage and breakage.

Another reason could be that participants were asked to keep mobile phone-based daily diaries, whereas past trials had asked volunteers to recall failure events up to several months later.

Monica Gandhi, an infectious disease doctor and medical director of an HIV clinic in San Francisco, welcomed the finding.

"The important thing about condoms is they don't just prevent HIV, but they prevent gonorrhea, chlamydia and syphilis," she told AFP, adding it was surprising that such an authorization had taken so long to achieve.

In its statement, the FDA said the green light could pave the way for more makers to apply for similar authorization if they show equivalent results.

D.Pan--ThChM